Revocation of the Color Additive Listing for Use of Orange B on Casings or Surfaces of Frankfurters and Sausages
FDA revoked the color additive listing for Orange B, used in frankfurter and sausage casings. Manufacturers must stop using it immediately.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 22, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Critical. Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B) that produce frankfurters or sausages with Orange B in casings. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate; no grace period.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Orange B is no longer listed as a permitted color additive for use on casings or surfaces of frankfurters and sausages.
Who it affects
Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B) that produce frankfurters or sausages with Orange B in casings.
What you must do
Cease use of Orange B in affected products immediately; reformulate or switch to approved alternatives.
Deadline
Immediate; no grace period.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Pay(or) Attention, Drug and Device Makers: FDA’s New Guidance for Talking to Health Plans - ArentFox Schiff
- Proposal to Revoke the Color Additive Listing for Use of Citrus Red No. 2 on the Skins of Mature Oranges
- UPDATE: Trump Signs Executive Order to Reschedule Cannabis and Expand Federal Policy - Foley Hoag
- US-CONGRESS BILLS-119hr2821eh: FDA Modernization Act 3.0
- US-CONGRESS BILLS-119hr9599ih: Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act; SECURE 340B Act